Evidence map›Paper›PMID 35053428›Full record

ArticleCancers2022

Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression.

Janson Tse, Thomas Pierce, Annalisa L E Carli, Mariah G Alorro, Stefan Thiem, Eric G Marcusson, Matthias Ernst, Michael Buchert

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Janson TseOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.
Thomas PierceOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.
Annalisa L E CarliOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.
Mariah G AlorroOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.
Stefan ThiemOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.
Eric G MarcussonRegulus Therapeutics, 10628 Science Center Drive, San Diego, CA 92121, USA.
Matthias ErnstOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.
Michael BuchertOlivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg 3084, Australia.ORCID 0000-0003-2672-0148
La Trobe University · AURegulus Therapeutics (United States) · US

Funding

Austin Medical Research Foundation Project grantGovernment of Victoria Operational Infrastructure Support ProgramNational Health and Medical Research Council 1079257National Health and Medical Research Council 1092788National Health and Medical Research Council 1173814
6 · The paper itself

Abstract

MicroRNA-21 (miR-21) is a small, non-coding RNA overexpressed in gastric cancer and many other solid malignancies, where it exhibits both pro-and anti-tumourigenic properties. However, the pathways regulating miR-21 and the consequences of its inhibition in gastric cancer remain incompletely understood. By exploiting the spontaneous Stat3-dependent formation of inflammation-associated gastric tumors in

Indexed as

antagomirEMTmiR-21Stat3stomach tumorTME

Identifiers

PMID35053428
PMCPMC8773769
OpenAlexW4205868463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.